1. Myalgias and back pain are most common with which drug used for treatment of erectile dysfunction?
A. sildenafil
B. tadalafil
C. vardenafil
D. alprostadil
2. Which of the following is an absolute contraindication to use of phosphodiesterase-5 inhibitors?
A. cytochrome P4503A4 inhibitors
B. diuretics
C. nitrates/nitrites
D. antipsychotic agents
3. How long does it take for 5α-reductase inhibitors to exhibit a therapeutic effect in BPH?
A. immediately
B. 1 to 2 weeks
C. 1 to 2 months
D. 3 to 6 months
4. Which of the following α1-receptor antagonists requires dose titration to minimize adverse effects?
A. alfuzosin
B. silodosin
C. tamsulosin
D. terazosin
5. True/False. Intraurethral suppositories are more effective than intracavernous injections for erectile dysfunction.
A. True
B. False
6. Which of the following drugs does NOT have to be dose-adjusted for concomitant use with cytochrome P4503A4 inhibitors?
A. sildenafil
B. tadalafil
C. darifenacin
D. oxybutynin
7. Which of the following is NOT a goal of therapy in benign prostatic hyperplasia?
A. relieve lower urinary tract symptoms
B. decrease bladder outlet obstruction
C. improve bladder emptying
D. prevent disease progression to prostate cancer
8. Which of the following disease states does NOT have any Food and Drug Administration-approved drugs for treatment?
A. benign prostatic hyperplasia
B. stress urinary incontinence
C. urge urinary incontinence
D. erectile dysfunction or neurogenic etiology
9. Which of the following is NOT a risk factor for erectile dysfunction?
A. diabetes
B. obesity
C. cigarette smoking
D. chronic obstructive pulmonary disease
10. Which of the following drugs is LEAST likely to contribute to erectile dysfunction?
A. enalapril
B. hydrochlorothiazide
C. atorvastatin
D. fluoxetine
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Will the information presented cause you to change your practice?
A. Yes
B. No
23. Are you committed to making these changes?
A. Yes
B. No
24. As a result of this activity, did you learn something new?
A. Yes
B. No
25. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology/Specialty Pharmacy
I. Industry/Manufacturing
26. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20